Northwire Canada EditionFriday, September 4, 2026
Northwire
GOLD 4539.90 +2.8% SILVER 67.58 +3.2% COPPER 6.67 +1.1% OIL 91.30 +0.3% PALLADIUM 1435.50 +5.5% SALT 1.65 +0.0% BBB 0.670 +3.1% SKE 45.71 +4.0% NOU 1.91 −4.0% LAM 0.660 +6.5% OGW 1.29 −5.2% COCO 0.300 +0.0% CPL 0.195 −11.4% FUU 0.145 −3.3% NUAG 9.25 −0.1% FDY 5.14 −1.9% GRZ 6.66 +0.1% TES 0.110 +10.0% MINK 0.100 +0.0% CAN 0.080 +0.0% ELEF 0.135 −12.9% GOLD 4539.90 +2.8% SILVER 67.58 +3.2% COPPER 6.67 +1.1% OIL 91.30 +0.3% PALLADIUM 1435.50 +5.5% SALT 1.65 +0.0% BBB 0.670 +3.1% SKE 45.71 +4.0% NOU 1.91 −4.0% LAM 0.660 +6.5% OGW 1.29 −5.2% COCO 0.300 +0.0% CPL 0.195 −11.4% FUU 0.145 −3.3% NUAG 9.25 −0.1% FDY 5.14 −1.9% GRZ 6.66 +0.1% TES 0.110 +10.0% MINK 0.100 +0.0% CAN 0.080 +0.0% ELEF 0.135 −12.9%
M&A / Property Routine +

DiagnaMed Completes Acquisition of Colchester East Natural Hydrogen Project in Nova Scotia

DiagnaMed Consolidates Nova Scotia Footprint Amidst Ontario Discovery Correction

Executive Summary
  • DiagnaMed Holdings Corp. announced the closing of its acquisition of the Colchester East Natural Hydrogen Project in Nova Scotia on May 15, 2026.
  • The transaction involved $10,000 cash and issuance of 10,000,000 common shares at an issue price of $0.06 per share.
  • The property comprises 30 licenses totaling 2,104 claims in the Cumberland Basin.
  • Vendors received a 2.0% gross revenue royalty on hydrogen or minerals produced, with an option for DiagnaMed to buy back 50% of this royalty for $2,000,000.
  • Directors and officers were granted 7,000,000 options at $0.075 exercise price with a two-year term.
  • This closing follows the initial acquisition agreement announced on December 10, 2025.
Material Impact
  • The news represents the execution of a previously announced transaction (December 2025), meaning market expectations were already priced in during the prior announcement phase.
  • Asset expansion is positive as it adds 30 licenses to the portfolio, diversifying beyond the Ontario Temiscamingue Graben into Nova Scotia.
  • Dilution risk exists with 10 million shares issued; however, at $0.06 per share ($600k value), this is a relatively small capital outlay compared to typical exploration budgets.
  • The royalty burden (2%) creates a future revenue obligation but includes a buy-back option for $2M which mitigates long-term cost if production scales.
  • No new financial catalysts or revenue milestones are disclosed; the impact is incremental asset accumulation rather than fundamental value creation.
DMED · Price
Company Overview
  • DiagnaMed Holdings Corp. focuses on natural hydrogen exploration in Canada.
  • Flagship Project: Ontario Temiscamingue Graben Hydrogen Corridor.
  • Recent Discovery (Oct 2025): Confirmed widespread natural hydrogen system with soil-gas anomalies exceeding 500 ppm H2, peaking at 2,817 ppm.
  • Expansion: Acquisition of Colchester East Natural Hydrogen Project in Nova Scotia adds jurisdictional diversity to the portfolio.
  • Technology Focus: Utilizes soil-gas surveys and plans for drilling to evaluate commercial potential.
Read the original news release →

More from Diagnamed Holdings Corp.